September 26, 2005
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| | |
Re: | | GENOMIC HEALTH, INC. |
| | Registration Statement on Form S-1 (File No. 333-126626) |
Ladies and Gentlemen:
As Representatives of the undersigned underwriters of the proposed public offering of up to 5,769,230 shares of Common Stock of Genomic Health, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:00 p.m. (NYT) on September 28, 2005, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated September 13, 2005, through the date hereof:
Preliminary Prospectus dated September 13, 2005:
12,955 copies to prospective Underwriters, institutional investors, dealers and others
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934.
| | | | |
| Very truly yours,
J.P. MORGAN SECURITIES INC. LEHMAN BROTHERS INC. PIPER JAFFRAY & CO. THOMAS WEISEL PARTNERS LLC JPM SECURITIES LLC | |
| | |
| | |
| | |
|
| | | | |
| BY: J.P. MORGAN SECURITIES INC. | |
| By: | /s/ Shelly Guyer | |
| | Name: Shelly Guyer | | |
| | Title: Vice President | | |
|
| | | | |
| BY: LEHMAN BROTHERS INC. | |
| By: | /s/ Arlene Salmonson | |
| | Arlene Salmonson | |
| | Vice President | |
|